Jeffrey A. Ferguson - Concepedia

Author

Jeffrey A. Ferguson

Eli Lilly (United States)

Also Known As

J FERGUSON, J Ferguson, J. Ferguson, Jeffrey A Ferguson, Jeffrey A. Ferguson

Publications

855

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Regenstrief Institute Richard L. Roudebush VA Medical Center Indiana University – Purdue University Indianapolis Indiana University School of Medicine

About

Jeffrey A. Ferguson is an author at Eli Lilly (United States) specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	498
2	Engineering	1	1	38
3	Law	1	1	11
4	Public Health	1	1	92
5	Epidemiology	1	1	92

Jeffrey A. Ferguson

Publications

714

Citations

H-Index

Page 1

	Year	Citations
Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure Michael D. Murray, Melissa Deer, Jeffrey A. Ferguson, The American Journal of Medicine Heart FailureStructural Heart DiseaseCardiovascular DiseaseClinical TrialsCardiovascular Pharmacology	2001	249
Risk factors for delirium tremens development Jeffrey A. Ferguson, Christopher J. Suelzer, George J. Eckert, Journal of General Internal Medicine PsychiatryGeriatricsRiskPsychopharmacologyTerminal Illness	1996	157
Examination of Racial Differences in Management of Cardiovascular Disease Jeffrey A. Ferguson, William M. Tierney, Glenda R. Westmoreland, Journal of the American College of Cardiology Health Care DisparityCardiovascular EpidemiologyCardiovascular DiseaseMedicineCardiology	1997	92
Racial Disparity in Cardiac Decision Making Jeffrey A. Ferguson, Morris Weinberger, Glenda R. Westmoreland, Archives of Internal Medicine	1998	68
Hyponatremia and syndrome of inappropriate anti‐diuretic hormone reported with the use of Vincristine®: an over‐representation of Asians? Isaac W. Hammond, Jeffrey A. Ferguson, Kenneth K. Kwong, Pharmacoepidemiology and Drug Safety	2002	44
Can raters consistently evaluate the content of focus groups? Morris Weinberger, Jeffrey A. Ferguson, Glenda R. Westmoreland, Social Science & Medicine Focus GroupsEngineeringSelection BiasEvaluation MeasureBias	1998	38
Two-Year Efficacy and Safety of AIR Inhaled Insulin in Patients with Type 1 Diabetes: An Open-Label Randomized Controlled Trial Satish K. Garg, Chantal Mathieu, Nadeem Rais, Diabetes Technology & Therapeutics	2009	24
Initiation of Prandial Insulin Therapy with AIR Inhaled Insulin or Insulin Lispro in Patients with Type 2 Diabetes: A Randomized Noninferiority Trial Jorge Luiz Gross, Masako Nakano, Gildred Colon-Vega, Diabetes Technology & Therapeutics	2009	21
Evaluation of Published Case Reports’ Standards and Notification Jeffrey A. Ferguson, Collen Mockbee, Sara M. Erbele, Drug Information Journal ReliabilityCase ManagementClinical Case ReportLawEvaluation	2002	11
Safety and Efficacy of AIR Inhaled Insulin Compared with Subcutaneous Insulin in Patients Having Diabetes and Asthma: A 12-Month, Randomized, Noninferiority Trial Ernesto Ang, Mary K. Lawrence, Cory R. Heilmann, Diabetes Technology & Therapeutics	2009	10

Page 1